Vanpowers Launches UrbanGlide in Europe. Custom-built for Commuters, the Connected, Intelligent E-bike Can Go 110 km on a Single Charge
Vanpowers officially announced the European launch of its latest e-bike, UrbanGlide — a precision-built, high torque, smooth-powered bike with a 500-watt motor designed for metro commuters and capable of traveling 110 kilometers on a single charge.
This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20230621166757/en/
Vanpowers latest e-bike UrbanGlide (Photo: Business Wire)
The UrbanGlide-Ultra is now available for pre-order for the early-bird price of €2,599.
The connected, intelligent e-bike can be experienced for the first time in Europe in person at EUROBIKE in Frankfurt between June 21st through June 25th at Hall 8.0 H32.
“We created UrbanGlide specifically for commuters navigating the concrete jungle,” said Darik Duan, chief of research and development at Vanpowers. “This is their tool--and toy. Every component--from the hydraulic brakes, powerful motor, the suspension fork, the ultra-comfortable suspension seatpost and saddle, the long-range battery, etc—was carefully considered. We are proud to have created a safe, reliable, cutting-edge e-bike that city dwellers will prefer to their cars.”
The following are key details about the UrbanGlide:
- Low cross frame and low step point are user-friendly, suitable for people of different ages and different body types
- 500W motor and sensitive torque sensor deliver quick acceleration and make the ride easy and smooth
- Battery charges to 90% in four hours
- Suspension seatpost with pressure-relieving saddle for ultra rider comfort
- Suspension front fork filters out vibrations and softens the impact of the road conditions
- Adjustable handlebar with 0-90 degree adjustment angle
- Lighting function for night riding
- UrbanGlide’s app allows riders to plan their routes, as well as track their speed, distance traveled, and calories burned
About Vanpowers
Founded in 2021 and run by a group of creative and conscientious cycling enthusiasts, Vanpowers has set the standard high for e-bikes. In addition to UrbanGlide, Vanpowers sells four other e-bikes, which are sold worldwide. With supply chains and local warehouses across the US, UK and Europe, Vanpowers offers fast shipping with deliveries usually taking between 3 to 7 days. For more information, please visit www.vanpowers.com.
To view this piece of content from cts.businesswire.com, please give your consent at the top of this page.
View source version on businesswire.com: https://www.businesswire.com/news/home/20230621166757/en/
Contact information
Tiff
(213) 221-5330
tiff@venturepr.co
About Business Wire
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
Parse Biosciences and Codebreaker Labs Partner to Apply Whole Transcriptome Single Cell Profiling and Causal Genomics at Scale19.12.2025 14:00:00 CET | Press Release
Parse Biosciences, the leading provider of scalable and accessible single cell sequencing solutions, today announced a collaboration with Codebreaker Labs to develop and validate a breakthrough platform capable of testing thousands of genetic variants in parallel and measuring their effects at single cell resolution. By combining Codebreaker’s synthetic biology platform and variant engineering capabilities with the scale and accessibility of Parse’s Evercode™ technology, the collaboration aims to generate the causal data increasingly sought by AI developers, drug discovery teams, and clinical researchers. Today’s genomic studies rely heavily on observational data, or variants that appear in large populations. But rare and private variants, often only seen in one individual or family, are nearly impossible to study this way because too few carriers of the variant exist to draw statistically meaningful conclusions. As a result, even the most advanced models trained on observational datas
Cinemo Launches Cinemo ICO ™ , Accelerating the AI-Driven Intelligent Cockpit19.12.2025 11:00:00 CET | Press Release
Cinemo, a global leader and highly innovative one-stop-shop provider for fully integrated digital media products announces today the launch of its next-generation, AI-powered cockpit solutions - Cinemo ICO™. By bringing agentic AI, Cinemo unlocks a truly intelligent cockpit - connecting vehicles, drivers, passengers, and their digital ecosystems into one seamless, personal and context-aware flow. The first product launched within the Cinemo ICO™ portfolio is Cinemo ICO™ MediaMind, enabling advanced intelligent media discovery. It combines the latest agentic AI technology with Cinemo’s core expertise of providing automotive-grade media management, helping users effortlessly discover the right content for every ride - perfectly matched to their taste, context, and environment. With Cinemo ICO™ MediaMind, the digital media experience evolves: using cutting-edge large language models and intelligent media metadata-search, it understands every request – even vague spoken commands, and turns
Cyviz Awarded Two Classified NATO Defense Contracts19.12.2025 08:00:00 CET | Press Release
Norwegian technology and platform company Cyviz AS has been awarded two classified defense contracts by major European NATO-partner nations to deliver a fully mobile, containerised Command & Control (C2) capability, strengthening Europe’s operational readiness in high-threat and expeditionary environments. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20251218625485/en/ Image from a previous military exercise where Cyviz demonstrated a mobile command center solution. The contracts cover the design, integration, and delivery of secure, deployable operations centres engineered to NATO security standards, enabling military and security forces to establish full theatre-class command capability wherever operations require. Due to the sensitive nature of the missions, contract value and customer identities remain undisclosed. From Demonstrated Readiness to Operational Deployment The awards follow growing interest among European def
S3NS Announces SecNumCloud Qualification for PREMI3NS, its Trusted Cloud Offering19.12.2025 07:00:00 CET | Press Release
S3NS, a subsidiary of Thales in partnership with Google Cloud, today announced that PREMI3NS, its "Trusted Cloud" (Cloud de confiance) offering, has received the SecNumCloud 3.2 qualification delivered by the French National Agency for the Security of Information Systems (ANSSI). Meeting SecNumCloud 3.2’s protection and resilience requirements, which are known as the most demanding ones in France and Europe, it offers immunity from non-European extraterritorial laws. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20251218817208/en/ ANSSI delivered the SecNumCloud 3.2 qualification for S3NS’ PREMI3NS offering, meeting all its requirements and passing all three milestones of the qualification process. With PREMI3NS, S3NS now offers businesses and public sector organizations the most extensive cloud service among the offerings that have received the SecNumCloud 3.2 qualification. PREMI3NS integrates the most advanced IaaS and Paa
Meiji Seika Pharma Partners With MBC BioLabs to Strengthen Global Innovation in Drug Discovery19.12.2025 02:00:00 CET | Press Release
Meiji Seika Pharma Co., Ltd. (Headquarters: Chuo-ku, Tokyo; President & CEO: Toshiaki Nagasato) today announced that it has entered into a partnership agreement with MBC BioLabs which is a private organization supporting the development of biotech startup companies in California’s San Francisco Bay Area. MBC BioLabs provides fully equipped research facilities and a supportive community that help biotech entrepreneurs accelerate from concept to company. By removing the burden of building and maintaining laboratory infrastructure, resident companies can focus early on research and development while efficiently advancing commercialization. Through this partnership, Meiji Seika Pharma will further advance its open-innovation initiatives and strengthen research and development in its priority therapeutic areas: infectious diseases, hematologic diseases, and immune-inflammatory diseases. By engaging with the entrepreneurs and startup community at MBC BioLabs, the company aims to discover inn
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom